Tessalia D.L. Saraiva, Katia Morais, Vanessa B. Pereira, Marcela de Azevedo, Clarissa S. Rocha, Camila C. Prosperi, Ana C. Gomes-Santos, Luis Bermudez-Humaran, Ana M.C. Faria, Herve M. Blottiere, Philippe Langella, Anderson Miyoshi, Alejandra de Moreno de LeBlanc, Jean G. LeBlanc and Vasco Azevedo
Paula dos P. Menezes, Adriano A. de S. Araujo, Grace Anne A. Doria, Lucindo J. Quintans-Junior, Makson G.B. de Oliveira, Marcio R.V. dos Santos, Juliana F. de Oliveira, Jivaldo do R. Matos, Flavio M. de S. Carvalho, Pericles B. Alves, Iara L. de Matos, Darlisson A. dos Santos, Ricardo N. Marreto, Gabriel F. da Silva and Mairim R. Serafini
Adriana C. Werner, Miriele C. Ferraz, Edson H. Yoshida, Natalia Tribuiani, Jean A.A. Gautuz, Monique N. Santana, Bruna A. Dezzotti, Vanessa G. de Miranda, Ameris L. Foramiglio, Sandro Rostelato-Ferreira, Renata V. da Silva Tavares, Stephen Hyslop and Yoko Oshima-Franco
Prof. Davide Prosperi is Associate Professor in Biochemistry at the University of Milano Bicocca (Unimib), Department of Biotechnology and Bioscience. Head of the NanoBioLab of Unimib, he is devoted to biomedical and biophysical applications of nanotechnology. In particular, the research activity of Davide Prosperi involves the design, synthesis, functionalization and characterization of colloidal, polymeric and biomimetic nanoparticles for biomedical applications, with particular focus on the diagnosis and treatment of cancer and inflammatory diseases. He is author of over 100 scientific publications. He is one of the author of the patent “Nanoconstructs with pharmacological activity” (n° WO2014013473-A1), and co-founder of the spin-off company inTHEna srl, aiming to design and development of molecules, nanostructures and technologies for biomedical studies and diagnosis, prevention and therapy of human and animal diseases.